Music |
Video |
Movies |
Chart |
Show |
ACTION: Natalizumab Did Not Reduce Infarct Volume (AHAScience) View | |
Extending Natalizumab's Use Without Increasing Risk to Patients (HCPLive) View | |
Additional Insights from Natalizumab Treatment in MS (Gavin Giovannoni) View | |
Evaluating Natalizumab’s Risk-Benefit Profile in MS (NeurologyLive) View | |
Natalizumab (Audiopedia) View | |
Natalizumab PML IRIS (MyNeuro News) View | |
CLEAR III: TPA for IVH Improved Mortality but Not Function (AHAScience) View | |
The Future of Stroke 2021: (Houston Methodist Neurological Institute) View | |
MR WITNESS: Expanding TPA for Unwitnessed Stroke (AHAScience) View | |
Strategies to Reverse Warfarin-related Coagulopathy in Patients with ICH (AHAScience) View |